Earnings Preview: Bristol-Myers to report 4Q

Published January 27, 2011

Earnings Preview: Bristol-Myers to report 4Q
Drugmaker Bristol-Myers Squibb Co., which reports its fourth-quarter results before the stock market opens Thursday, likely will focus on how recent and pending approvals of new drugs could help offset a looming revenue plunge as patents on key drugs expire.
Read more on AP via Yahoo! News

Bill Would Treat Marijuana Like Liquor, Generate 0 Million Per Year for Washington
For the second consecutive year, state representative Mary Lou Dickerson has introduced a bill (HB 1550) that would legalize and tax marijuana. If the legislation is approved–and that’s a c…
Read more on Seattle Weekly

Oxford BioTherapeutics Out-Licenses Therapeutic Antibody for the Treatment of Solid Cancers
OXFORD, England, January 25, 2011 /PRNewswire/ Oxford BioTherapeutics (OBT) today announces that sanofi-aventis has acquired an exclusive world-wide license to one of OBT´s internal preclinical antibody programs. sanofi-aventis intends to …
Read more on wallstreet:online AG